|
시장보고서
상품코드
2049778
기존 상처 관리 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)Traditional Wound Management Market Report by Product (Gauze, Tape, Bandages, Cotton), Application (Chronic Wounds, Acute Wounds), End User (Hospitals and Clinics, Home Healthcare, Ambulatory Surgical Centers, and Others), and Region 2026-2034 |
||||||
세계의 기존 상처 관리 시장 규모는 2025년에 62억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 84억 달러에 달하고, 2026년부터 2034년까지 CAGR 3.35%로 성장할 것으로 예측했습니다. 만성 및 급성 상처의 유병률 증가, 수술 건수 증가, 치명적인 교통 사고 발생 건수 증가, 의료 인프라의 지속적인 개선이 시장을 이끄는 주요 요인 중 일부입니다.
기존 상처 관리는 임상용 드레싱, 면봉, 거즈 등 다양한 상처 관리 제품을 사용하여 상처 세척, 치유 촉진, 지혈을 하는 것을 말합니다. 이는 상처액 흡수, 감염 관리 및 예방, 기계적 요인 제어, 콜라겐 성숙 촉진에 도움이 됩니다. 또한 상처의 오염을 방지하는 역할도 하며, 일반적으로 삼출액이 적은 급성 및 만성 상처에 주로 사용되며, 1차 또는 2차 드레싱으로 사용됩니다. 수술 상처, 당뇨병성 족부궤양, 욕창, 정맥성 하지 궤양, 동맥성 궤양 등 광범위한 만성 상처 관리에 널리 사용되고 있습니다. 그 결과, 기존 상처 관리는 전 세계 의료 현장에서 화상, 외상, 부상 및 수술 상처 치료에 광범위하게 적용되고 있습니다.
기존 상처 관리 시장 동향:
급성 상처 및 경미한 부상의 발생 건수 증가는 시장 성장을 이끄는 주요 요인 중 하나입니다. 또한, 전 세계적으로 수술 건수가 증가함에 따라 수술 후 감염(SSI) 예방, 치료 결과 개선, 환자 관리 강화 및 입원 기간 단축을 위해 기존 상처 관리 제품에 대한 수요가 증가하고 있습니다. 이는 흡연 습관, 좌식 생활습관, 과도한 알코올 섭취로 인한 비뇨기 질환, 암, 심혈관질환(CVD), 신경혈관 질환, 비만, 당뇨병 등 만성질환의 높은 유병률에 기인하는 것으로 추정됩니다. 여기에 외래 수술 센터(ASC) 설립 급증과 치명적인 교통사고 발생 건수 증가가 제품 수요를 견인하고 있습니다. 또한, 외래 및 통원 치료 센터에서의 첨단 상처 치료 방법의 채택이 확대되면서 시장 성장을 촉진하고 있습니다. 이에 따라 유리한 상환 정책의 보급과 의료 인프라 개선을 위한 각국 정부의 막대한 투자가 시장 성장을 촉진하고 있습니다. 또한, 주요 기업들의 지속적인 제품 혁신(예 : 스프레이형 및 스마트 붕대 출시, 새로운 외용 연고, 접착 붕대 디자인 변형 등)이 시장 성장을 주도하고 있습니다. 이 밖에도 고령 인구 증가, 최소침습(MI) 미용 시술의 보급 확대, 재택 의료의 부상, 소비자의 의료비 지출 증가, 광범위한 연구개발(R&D) 활동 등이 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.
본 보고서에서 답변하는 주요 질문
- 세계 기존 상처 관리 시장은 지금까지 어떤 추세를 보여 왔으며, 향후 몇 년 동안 어떤 추세를 보일 것인가?
- 세계 기존 상처 관리 시장의 촉진요인, 억제요인 및 기회는 무엇인가?
- 각 촉진요인, 제약요인 및 기회는 세계 기존 상처 관리 시장에 어떤 영향을 미치는가?
- 주요 지역 시장은 어디인가?
- 가장 매력적인 기존 상처 관리 시장을 대표하는 국가는 어디인가?
- 제품별로 보면 시장 내역은 어떠한가?
- 기존 상처 관리 시장에서 가장 매력적인 제품은 무엇인가?
- 용도별 시장 현황은 어떠한가?
- 기존 상처 관리 시장에서 가장 매력적인 용도는 무엇인가?
- 최종사용자별 시장 현황은 어떠한가?
- 기존 상처 관리 시장에서 가장 매력적인 최종사용자는 누구인가?
- 세계 기존 상처 관리 시장의 경쟁 구조는 어떻게 형성되어 있는가?
- 세계 기존 상처 관리 시장의 주요 플레이어/기업은 어디인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 기존 상처 관리 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 촉진요인, 억제요인, 기회
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSMThe global traditional wound management market size reached USD 6.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2034, exhibiting a growth rate (CAGR) of 3.35% during 2026-2034. The rising prevalence of chronic and acute wounds, the increasing number of surgical procedures, escalating incidences of fatal road accidents, and ongoing improvements in healthcare infrastructure represent some of the key factors driving the market.
Traditional wound management refers to the use of various wound care products, such as clinical dressings, cotton pads, and gauzes, to clean the wound, promote faster healing, and stop bleeding. It aids in absorbing wound fluids, managing and preventing infections, controlling mechanical influences, and improving collagen maturation. It also assists in protecting the wound from contamination and is generally preferred for acute and chronic wounds with mild exudate levels and employed as primary or secondary dressings. It is widely used to manage a range of chronic wounds, such as surgical incisions, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and arterial ulcers. As a result, traditional wound management finds extensive applications in healthcare settings for treating burns, trauma, injuries, and surgical wounds across the globe.
TRADITIONAL WOUND MANAGEMENT MARKET TRENDS:
The rising instances of acute wounds and minor injuries represent one of the key factors supporting the market growth. Moreover, the increasing number of surgical procedures across the globe has generated the need for traditional wound management products to prevent surgical-site infections (SSIs), improve treatment outcomes, enhance patient care, and reduce the duration of hospital stays. This can be attributed to the high prevalence of chronic diseases, such as urological disorders, cancer, cardiovascular diseases (CVDs), neurovascular conditions, obesity, and diabetes, due to smoking habits, sedentary lifestyles, and excessive alcohol consumption. Besides this, a surge in the establishment of ambulatory surgical centers (ASCs) and the escalating incidences of fatal road accidents have catalyzed product demand. In addition, the rising adoption of advanced wound care practices in ambulatory and outpatient centers is augmenting the market growth. In line with this, the widespread availability of favorable reimbursement policies and heavy investments by governments of various countries in improving healthcare infrastructure has propelled market growth. Furthermore, ongoing product innovations by key players, such as the launch of spray and smart bandages, new topical ointments, and design variations in adhesive bandages, are driving the market toward growth. Other factors, including the expanding geriatric population, increasing adoption of minimally invasive (MI) cosmetic procedures, emerging home healthcare trends, inflating consumer healthcare spending, and extensive research and development (R&D) activities, are also anticipated to provide a positive thrust to the market growth.
KEY MARKET SEGMENTATION:
Product Insights:
- Gauze
- Tape
- Bandages
- Cotton
Application Insights:
- Chronic Wounds
- Acute Wounds
End User Insights:
- Hospitals and Clinics
- Home Healthcare
- Ambulatory Surgical Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for traditional wound management. Some of the factors driving the North America traditional wound management market included its aging population, growing burden of cancer, high healthcare expenditure, rising number of ASCs in the region, etc.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global traditional wound management market. Detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Cardinal Health Inc., Datt Mediproducts Pvt Ltd., DeRoyal Industries Inc., Dukal LLC, Essity AB, Medtronic plc, Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew plc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
KEY QUESTIONS ANSWERED IN THIS REPORT
- How has the global traditional wound management market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global traditional wound management market?
- What is the impact of each driver, restraint, and opportunity on the global traditional wound management market?
- What are the key regional markets?
- Which countries represent the most attractive traditional wound management market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the traditional wound management market?
- What is the breakup of the market based on the application?
- Which is the most attractive application in the traditional wound management market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the traditional wound management market?
- What is the competitive structure of the global traditional wound management market?
- Who are the key players/companies in the global traditional wound management market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Traditional Wound Management Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Gauze
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Tape
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Bandages
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Cotton
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Application
- 7.1 Chronic Wounds
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Acute Wounds
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Home Healthcare
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Ambulatory Surgical Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 B. Braun Melsungen AG
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 SWOT Analysis
- 14.3.2 Cardinal Health Inc.
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Datt Mediproducts Pvt Ltd
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 DeRoyal Industries Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Dukal LLC
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Essity AB
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.7 Medtronic plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Molnlycke Health Care AB
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 SWOT Analysis
- 14.3.9 Paul Hartmann AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 Smith & Nephew plc
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 B. Braun Melsungen AG
